Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-066654 General Corporate
Debt relative to revenue 20th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
93.71% · OPTIONAL · VALID
Capex intensity 7th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.74% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.55% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
-10.19% · CORE · VALID
Gross margin 40th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
67.68% · CORE · VALID
Operating margin 20th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
-9.24% · CORE · VALID
R&D intensity 93th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
41.88% · OPTIONAL · VALID
SBC intensity 53th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
13.84% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 453.13%
Current 93.71%
Delta -359.42% Capex Intensity Decreased
Previous 2.47%
Current 1.74%
Delta -0.73% Cash Generation Increased
Previous -13.29%
Current 2.55%
Delta 15.84% Growth Increased
Previous -30.75%
Current -10.19%
Delta 20.56% Margin Increased
Previous 66.04%
Current 67.68%
Delta 1.64% Profitability Increased
Previous -13.79%
Current -9.24%
Delta 4.55% R And D Intensity Decreased
Previous 48.98%
Current 41.88%
Delta -7.10% Sbc Intensity Increased
Previous 11.31%
Current 13.84%
Delta 2.53% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.